Toggle light / dark theme

The best solar company in Australia just installed my new solar system.
Check them out here: https://www.resinc.com.au/electricviking.

I use Starlink internet to upload all of my videos, use my referral link here: https://www.starlink.com/residential?referral=RC-392400-91086-9

👇👇 Buy something and support The Electric Viking Store 👇👇
https://shop.theelectricviking.com/

Size guide and other help for the store 👇

The Electric Viking Products Size Guide.

🔔 Subscribe and hit the notification bell! â–ș

We are ready to unveil the world’s first real-world speeder bike.
Stay tuned for the official launch video soon.

Subscribe and check out new videos.
#speederbike #hoverbike #starwars #jetpack #ironman #futuretech #flying #airbike #teaser.

https://twitter.com/Volonaut.
https://www.tiktok.com/@volonaut.
https://www.facebook.com/volonaut.
https://www.instagram.com/volonaut.
https://www.linkedin.com/company/volonaut/

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukemia Research Institute, have developed an innovative CAR-T cell therapy targeting the CD30 protein (HSP-CAR30), which has shown high efficacy in patients with refractory CD30+ lymphoma.

A Phase I clinical trial, whose results have been published in the journal Blood, reveals that this new CAR-T30 therapy promotes the expansion of memory T cells, leading to long-lasting responses and improved clinical outcomes in treated patients.

Hodgkin and other CD30+ lymphomas have posed a significant challenge to the medical community, particularly in refractory or relapsed cases where conventional treatments have so far shown limited efficacy.